Strategies for the management of hepatocellular carcinoma
- 1 July 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Clinical Practice Oncology
- Vol. 4 (7), 424-432
- https://doi.org/10.1038/ncponc0844
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular CarcinomaJNCI Journal of the National Cancer Institute, 2005
- Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcomeEuropean Journal of Surgical Oncology, 2004
- Adjuvant intra-arterial injection of iodine-131–labeled lipiodol after resection of hepatocellular carcinomaHepatology, 2003
- Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survivalLiver Transplantation, 2003
- Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinomaHepatology, 2003
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- Comparison of Surgical Outcomes for Hepatocellular Carcinoma in Patients With Hepatitis B Versus Hepatitis C: A Western ExperienceAnnals of Surgical Oncology, 2000
- Terminology of nodular hepatocellular lesionsHepatology, 1995
- Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCCLiver International, 1987